Back to search

North Dakota State University

Bioprinting of Pancreatic Cancer Cells for Improved Drug Testing

Abstract

dc:description.abstract

Currently, many drugs are preclinically tested on two-dimensional cell cultures. However, this method does not adequately replicate the cellular interactions or diffusion gradient that occur in three-dimensional tissues, leading to poor indicators of how a drug may affect human tissues. The objective of this project was to use bioprinted pancreatic cancer cell cultures as a platform for three-dimensional drug testing. Various bioink formulations of cellulose, gelatin, and alginate were evaluated to determine which provided the best printability and cell viability. A cellulose nanocrystal and alginate hydrogel showed superior printability due to its shear thinning properties. Additionally, initial cell viability was nearly 80%, and it remained above 60% over four days. Use of a custom spinning bioreactor at 50 rpm resulted in no improvements to cell viability. Overall, the system shows potential as a drug testing platform to evaluate the effectiveness of various drug formulations on three-dimensional pancreatic cancer cell cultures.

Degree

thesis:*
Grantor dc:publisher
North Dakota State University
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Rehovsky, Chad Austin

Subjects

dc:subject × 4

Rights

dc:rights
Statement dc:rights
  • NDSU policy 190.6.2

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/10365/31696

Chain of custody

source
Harvested from
North Dakota State University
Base URL
library.ndsu.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Rehovsky, Chad Austin. Bioprinting of Pancreatic Cancer Cells for Improved Drug Testing. North Dakota State University, 2019. https://hdl.handle.net/10365/31696